Clinical trials
Completed Neoplasms trials in the United Kingdom
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
430 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 2 |
| 2002 | 4 |
| 2003 | 2 |
| 2004 | 4 |
| 2005 | 15 |
| 2006 | 13 |
| 2007 | 27 |
| 2008 | 17 |
| 2009 | 17 |
| 2010 | 21 |
| 2011 | 24 |
| 2012 | 20 |
| 2013 | 36 |
| 2014 | 28 |
| 2015 | 37 |
| 2016 | 27 |
| 2017 | 19 |
| 2018 | 27 |
| 2019 | 21 |
| 2020 | 18 |
| 2021 | 20 |
| 2022 | 15 |
| 2023 | 7 |
| 2024 | 2 |
| 2025 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 430 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 34 |
| Novartis Pharmaceuticals | 22 |
| GlaxoSmithKline | 16 |
| Bayer | 12 |
| Hoffmann-La Roche | 12 |
| Pfizer | 11 |
| Royal Marsden NHS Foundation Trust | 10 |
| AbbVie | 9 |
| Boehringer Ingelheim | 9 |
| Imperial College London | 9 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Neoplasms | 430 |
| Breast Neoplasms | 31 |
| Neoplasm Metastasis | 28 |
| Prostatic Neoplasms | 21 |
| Carcinoma, Non-Small-Cell Lung | 20 |
| Carcinoma | 17 |
| Carcinoma, Renal Cell | 17 |
| Colorectal Neoplasms | 17 |
| Melanoma | 17 |
| Ovarian Neoplasms | 13 |
Trials
Showing 1 to 25 of 430. Each trial links to its page on Pharma Observatory.
330 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.